"At Knoxville Heart Group we strive to achieve the highest level of quality service in cardiology. Our practice is a multi-physician group of expert cardiologists, interventional cardiologists and electrophysiologists who have served Knoxville and East Tennessee for more than 35 years. Through the use of advanced technologies and procedures, we provide you complete heart care."

During the past decade, Knoxville Heart Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Knoxville Heart Group" #1 collaborator was "Pfizer" with 2 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Knoxville Heart Group" are "Atrial Fibrillation" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Atrial Flutter" (1 trials). Many other conditions were trialed in "Knoxville Heart Group" in a lesser frequency.

Most popular intervention types in "Knoxville Heart Group" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (2 trials), "Acetylsalicylic acid" (1 trials), "Placebo" (1 trials), "apixaban" (1 trials) and "warfarin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Knoxville Heart Group" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Knoxville Heart Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Knoxville Heart Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Knoxville Heart Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".